Natural Product: NPC471053

Natural Product IDNPC471053
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Symplostatin 5
IUPAC Name sodium;[(2R)-3-[[(2S)-1-[[(2S,5S,8S,11R,12S,15Z,18S,21R)-2,5-dibenzyl-8-[(2R)-butan-2-yl]-15-ethylidene-21-hydroxy-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentazabicyclo[16.3.1]docosan-12-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-2-methoxy-3-oxopropyl] sulfate
Synonyms Symplostatin 5
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2338554
PubChem CID 71711730
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0001813] Peptidomimetics
        • [CHEMONTID:0001961] Depsipeptides
          • [CHEMONTID:0001994] Cyclic depsipeptides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey KPKJQINJXGFAPS-NBGICTFWSA-M
Standard InCHI InChI=1S/C47H65N7O15S.Na/c1-9-27(5)38-47(63)69-28(6)39(52-43(59)37(26(3)4)50-42(58)35(67-8)25-68-70(64,65)66)44(60)48-31(10-2)40(56)49-32-21-22-36(55)54(45(32)61)34(24-30-19-15-12-16-20-30)46(62)53(7)33(41(57)51-38)23-29-17-13-11-14-18-29;/h10-20,26-28,32-39,55H,9,21-25H2,1-8H3,(H,48,60)(H,49,56)(H,50,58)(H,51,57)(H,52,59)(H,64,65,66);/q;+1/p-1/b31-10-;/t27-,28-,32+,33+,34+,35-,36-,37+,38+,39+;/m1./s1
SMILES CC[C@H]([C@@H]1N=C(O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](Cc2ccccc2)N2[C@H](O)CC[C@@H](C2=O)N=C(/C(=C/C)/N=C([C@H]([C@H](OC1=O)C)N=C([C@H](C(C)C)N=C([C@@H](COS(=O)(=O)O)OC)O)O)O)[O-])C.[Na+]

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   998.42 Volume:   973.717
?
Van der Waals volume.
Dense:   1.025 LogP:   -0.452
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.408
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -1.438
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   15.0 Rigid Bonds:   43.0
TPSA:   325.76
?
Topological Polar Surface Area.
H-Bond Acceptor:   22.0
H-Bond Donor:   6.0 Rings:   4.0
Heavy Atoms:   23.0

MedChem Properties

QED Drug-Likeness Score:   0.065 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.607 Fsp3:   0.532
MCE-18:   126.75
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.618 Fluc inhibitor:   0.048
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.034
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.846
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.013 Promiscuous compounds:   0.021

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.57 MDCK Permeability:   -5.04
Pgp-inhibitor:   0.98 Pgp-substrate:   0.998
PAMPA:   0.289
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.878
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.523
Plasma Protein Binding (PPB):   71.249% Volume Distribution (VD):   -0.631
Fu: 30.012%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.993 BCRP inhibitor:   0.001
BSEP inhibitor:   0.99

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.001 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.999 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.031
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.315 Half-life (T1/2):  2.237

ADMET: Toxicity

hERG Blockers:  0.001 hERG Blockers (10um):  0.0
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  0.043 Rat Oral Acute Toxicity:  0.415
Maximum Recommended Daily Dose:  0.992 Skin Sensitization:  1.0
Carcinogencity:  0.125 Eye Corrosion:  0.0
Eye Irritation:  0.0 Respiratory Toxicity:  0.893
Drug-induced Neurotoxicity:  0.021 Ototoxicity:  0.999
Hematotoxicity:  0.212 Drug-induced Nephrotoxicity:  0.999
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.006
BCF:   0.448
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.241
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.942
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.167
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33098 cyanobacteria Phylum n.a. Bacteria n.a. n.a. n.a. PMID[19715320]
NPO33098 cyanobacteria Phylum n.a. Bacteria n.a. n.a. n.a. PMID[23350733]
NPO33098 cyanobacteria Phylum n.a. Bacteria n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1654 Individual protein Urokinase-type plasminogen activator Homo sapiens IC50 < 10000.0 nM PMID[16933872]
NPT2785 Individual protein Tryptase beta-1 Homo sapiens IC50 < 10000.0 nM PMID[16933872]
NPT1720 Individual protein Plasminogen Homo sapiens IC50 < 10000.0 nM PMID[10395508]
NPT2533 Individual protein Coagulation factor X Homo sapiens IC50 < 10000.0 nM PMID[19546358]
NPT279 Individual protein Leukocyte elastase Homo sapiens IC50 < 10000.0 nM PMID[19546358]
NPT1547 Individual protein Cathepsin D Homo sapiens Activity = 100.0 % PMID[12951092]
NPT1090 Individual protein Matrix metalloproteinase 13 Homo sapiens Activity = 100.0 % PMID[1517739]
NPT1089 Individual protein Matrix metalloproteinase 12 Homo sapiens Activity = 100.0 % PMID[25856683]
NPT280 Individual protein Matrix metalloproteinase 9 Homo sapiens Activity = 100.0 % PMID[25856683]
NPT1166 Individual protein Angiotensin-converting enzyme Homo sapiens Activity = 100.0 % PMID[21035332]
NPT201 Individual protein Papain Carica papaya Activity = 100.0 % PMID[19167886]
NPT214 Individual protein Cathepsin B Homo sapiens Activity = 100.0 % PMID[21035332]
NPT2265 Individual protein Caspase-9 Homo sapiens Activity = 75.0 % PubChem BioAssay data set
NPT1226 Individual protein Caspase-7 Homo sapiens Activity = 100.0 % PMID[20624681]
NPT277 Individual protein Caspase-1 Homo sapiens Activity = 50.0 % PMID[23316950]
NPT1654 Individual protein Urokinase-type plasminogen activator Homo sapiens Activity = 100.0 % PMID[12617583]
NPT2785 Individual protein Tryptase beta-1 Homo sapiens Activity = 100.0 % PMID[12617583]
NPT1720 Individual protein Plasminogen Homo sapiens Activity = 100.0 % PMID[12617583]
NPT2533 Individual protein Coagulation factor X Homo sapiens Activity = 100.0 % PMID[17157006]
NPT279 Individual protein Leukocyte elastase Homo sapiens Activity = 0.0 % PMID[15050621]
NPT278 Individual protein Cathepsin G Homo sapiens Activity = 50.0 % PMID[8632405]
NPT1592 Individual protein Dipeptidyl peptidase IV Homo sapiens Activity = 100.0 % PMID[21534539]
NPT278 Individual protein Cathepsin G Homo sapiens IC50 < 10000.0 nM PMID[17524651]
NPT279 Individual protein Leukocyte elastase Homo sapiens Inhibition = 22.0 % PMID[19674905]
NPT279 Individual protein Leukocyte elastase Homo sapiens Inhibition = 42.0 % Open TG-GATES in vivo data: Organ Weight
NPT279 Individual protein Leukocyte elastase Homo sapiens Inhibition = 34.0 % PMID[19827833]
NPT279 Individual protein Leukocyte elastase Homo sapiens Inhibition = 46.0 % PMID[18808182]
NPT279 Individual protein Leukocyte elastase Homo sapiens Inhibition = 53.0 % PMID[19942326]
NPT279 Individual protein Leukocyte elastase Homo sapiens Inhibition = 49.0 % PMID[23398362]
NPT279 Individual protein Leukocyte elastase Homo sapiens Inhibition = 56.0 % PMID[19942326]
NPT279 Individual protein Leukocyte elastase Homo sapiens Inhibition = 58.0 % PMID[19942326]
NPT279 Individual protein Leukocyte elastase Homo sapiens Activity > 75.0 % PMID[10087141]
NPT279 Individual protein Leukocyte elastase Homo sapiens IC50 = 77.5 nM DrugMatrix in vitro pharmacology data
NPT279 Individual protein Leukocyte elastase Homo sapiens IC50 = 144.0 nM PMID[23357036]
NPT279 Individual protein Leukocyte elastase Homo sapiens IC50 = 93.0 nM PMID[33002682]
NPT6425 Individual protein Kallikrein 8 Homo sapiens IC50 < 10000.0 nM PMID[15497936]
NPT4197 Individual protein Coagulation factor XI Homo sapiens IC50 < 10000.0 nM PMID[19546358]
NPT6254 Individual protein Coagulation factor VII Homo sapiens IC50 < 10000.0 nM PMID[19721071]
NPT6326 Individual protein Vitamin K-dependent protein C Homo sapiens IC50 < 10000.0 nM PMID[18183025]
NPT6325 Individual protein Matrix metalloproteinase 10 Homo sapiens Activity = 100.0 % PMID[25856683]
NPT5085 Individual protein Cathepsin H Homo sapiens Activity = 100.0 % PMID[21035332]
NPT3579 Individual protein Calpain 1 Homo sapiens Activity = 100.0 % PMID[12617583]
NPT6425 Individual protein Kallikrein 8 Homo sapiens Activity = 50.0 % PMID[11551769]
NPT4197 Individual protein Coagulation factor XI Homo sapiens Activity = 75.0 % PMID[17157006]
NPT6254 Individual protein Coagulation factor VII Homo sapiens Activity = 100.0 % PMID[21982796]
NPT6326 Individual protein Vitamin K-dependent protein C Homo sapiens Activity = 100.0 % PMID[8632405]
NPT6386 Individual protein Dipeptidyl peptidase I Homo sapiens Activity = 50.0 % PMID[8632405]
NPT6416 Individual protein Dipeptidyl peptidase VIII Homo sapiens Activity = 100.0 % PMID[10560729]
NPT6294 Individual protein Tryptase gamma Homo sapiens IC50 < 10000.0 nM PMID[16933872]
NPT5075 Individual protein Plasma kallikrein Homo sapiens IC50 < 10000.0 nM PMID[15497936]
NPT6648 Individual protein Kallikrein 14 Homo sapiens IC50 < 10000.0 nM PMID[9584401]
NPT6321 Individual protein Kallikrein 12 Homo sapiens IC50 < 10000.0 nM PMID[10395498]
NPT6500 Individual protein Kallikrein 1 Homo sapiens IC50 < 10000.0 nM PMID[20888765]
NPT740 Individual protein Beta-secretase 1 Homo sapiens Activity = 100.0 % PMID[12932124]
NPT4015 Individual protein Matrix metalloproteinase 14 Homo sapiens Activity = 100.0 % DOI[10.6019/CHEMBL1201861]
NPT4016 Individual protein Matrix metalloproteinase 7 Homo sapiens Activity = 100.0 % PMID[25856683]
NPT567 Individual protein Matrix metalloproteinase 3 Homo sapiens Activity = 100.0 % PMID[1517739]
NPT69 Individual protein Matrix metalloproteinase-1 Homo sapiens Activity = 100.0 % PMID[25856683]
NPT6430 Individual protein Caspase-10 Homo sapiens Activity = 100.0 % PMID[20624681]
NPT979 Individual protein Caspase-3 Homo sapiens Activity = 100.0 % PubChem BioAssay data set
NPT4104 Individual protein Caspase-2 Homo sapiens Activity = 75.0 % PubChem BioAssay data set
NPT6294 Individual protein Tryptase gamma Homo sapiens Activity = 100.0 % PMID[12617583]
NPT5075 Individual protein Plasma kallikrein Homo sapiens Activity = 50.0 % PMID[12617583]
NPT6648 Individual protein Kallikrein 14 Homo sapiens Activity = 75.0 % PMID[12217376]
NPT6321 Individual protein Kallikrein 12 Homo sapiens Activity = 0.0 % PMID[12217376]
NPT6500 Individual protein Kallikrein 1 Homo sapiens Activity = 100.0 % PMID[12217376]
NPT6487 Individual protein Dipeptidyl peptidase IX Homo sapiens Activity = 100.0 % PMID[8632405]
NPT6616 Individual protein Tissue-type plasminogen activator Homo sapiens IC50 < 10000.0 nM PMID[15497936]
NPT6352 Individual protein Kallikrein 13 Homo sapiens IC50 < 10000.0 nM PMID[16252909]
NPT6580 Individual protein Granzyme B Homo sapiens IC50 < 10000.0 nM PMID[19546358]
NPT6299 Individual protein ADAM10 Homo sapiens Activity = 100.0 % DOI[10.6019/CHEMBL1201861]
NPT6515 Individual protein ADAM9 Homo sapiens Activity = 100.0 % PMID[18280170]
NPT4211 Individual protein Caspase-8 Homo sapiens Activity = 100.0 % PMID[20624681]
NPT6608 Individual protein Caspase-5 Homo sapiens Activity = 100.0 % PMID[24900739]
NPT6616 Individual protein Tissue-type plasminogen activator Homo sapiens Activity = 100.0 % PMID[12617583]
NPT6352 Individual protein Kallikrein 13 Homo sapiens Activity = 100.0 % PMID[12217376]
NPT6580 Individual protein Granzyme B Homo sapiens Activity = 100.0 % PMID[12217376]
NPT1644 Protein family Trypsin Homo sapiens IC50 < 10000.0 nM PMID[16933872]
NPT4971 Individual protein Kallikrein 5 Homo sapiens IC50 < 10000.0 nM PMID[20888765]
NPT6373 Individual protein Complement C1s Homo sapiens IC50 < 10000.0 nM PMID[19721071]
NPT6510 Individual protein Cathepsin E Homo sapiens Activity = 100.0 % DOI[10.6019/CHEMBL1201861]
NPT3910 Individual protein ADAM17 Homo sapiens Activity = 100.0 % DOI[10.6019/CHEMBL1201861]
NPT6520 Individual protein Matrix metalloproteinase 11 Homo sapiens Activity = 100.0 % PMID[25856683]
NPT569 Individual protein Matrix metalloproteinase 8 Homo sapiens Activity = 100.0 % PMID[25856683]
NPT568 Individual protein Matrix metalloproteinase-2 Homo sapiens Activity = 100.0 % PMID[25856683]
NPT6391 Individual protein Cathepsin Z Homo sapiens Activity = 100.0 % PMID[21035332]
NPT601 Individual protein Cathepsin L2 Homo sapiens Activity = 100.0 % PMID[9651160]
NPT5930 Individual protein Cathepsin S Homo sapiens Activity = 100.0 % PMID[11421737]
NPT3595 Individual protein Cathepsin K Homo sapiens Activity = 100.0 % PMID[11421737]
NPT6470 Individual protein Caspase-14 Homo sapiens Activity = 100.0 % PMID[20420415]
NPT867 Individual protein Caspase-6 Homo sapiens Activity = 100.0 % PMID[23215246]
NPT6575 Individual protein Caspase-4 Homo sapiens Activity = 100.0 % PMID[20624681]
NPT1644 Protein family Trypsin Homo sapiens Activity = 75.0 % PMID[17428663]
NPT4971 Individual protein Kallikrein 5 Homo sapiens Activity = 75.0 % DOI[10.6019/CHEMBL1201861]
NPT5013 Individual protein Chymase Homo sapiens Activity = 100.0 % PMID[21982796]
NPT6373 Individual protein Complement C1s Homo sapiens Activity = 75.0 % PMID[12061886]
NPT5013 Individual protein Chymase Homo sapiens IC50 < 10000.0 nM PMID[17524651]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified n.a. IC50 < 10000.0 nM PMID[19161316]
NPT2 Others Unspecified n.a. IC50 = 63.1 nM PMID[19721071]
NPT2 Others Unspecified n.a. IC50 = 794.33 nM PMID[19721071]
NPT2 Others Unspecified n.a. Activity = 0.0 % PMID[15050621]
NPT2 Others Unspecified n.a. Activity = 75.0 % PMID[14584959]
NPT2 Others Unspecified n.a. Activity = 100.0 % PMID[12217376]
NPT2 Others Unspecified n.a. Activity = 53.4 % PMID[10691710]
NPT2 Others Unspecified n.a. IC50 > 10000.0 nM PMID[19161316]
NPT2 Others Unspecified n.a. IC50 = 322.0 nM PMID[19660948]
NPT2 Others Unspecified n.a. IC50 = 68.0 nM PMID[18364258]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC471053 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.96 High Similarity NPC471051
0.9495 High Similarity NPC471052
0.7857 Intermediate Similarity NPC471048
0.7748 Intermediate Similarity NPC471050
0.6417 Remote Similarity NPC471526
0.6016 Remote Similarity NPC63040
0.5891 Remote Similarity NPC163961
0.584 Remote Similarity NPC473407
0.5833 Remote Similarity NPC489838
0.5802 Remote Similarity NPC489835
0.5802 Remote Similarity NPC489836
0.5625 Remote Similarity NPC302715
0.5615 Remote Similarity NPC61332
0.56 Remote Similarity NPC22883
0.5564 Remote Similarity NPC489837
0.5556 Remote Similarity NPC194671
0.552 Remote Similarity NPC279871
0.552 Remote Similarity NPC5719
0.5469 Remote Similarity NPC269750
0.5469 Remote Similarity NPC294951
0.5448 Remote Similarity NPC240130
0.541 Remote Similarity NPC306804
0.5385 Remote Similarity NPC60516
0.5379 Remote Similarity NPC488263
0.5349 Remote Similarity NPC15068
0.5267 Remote Similarity NPC159767
0.5227 Remote Similarity NPC155506
0.521 Remote Similarity NPC239762
0.5161 Remote Similarity NPC62104
0.5156 Remote Similarity NPC137627
0.5147 Remote Similarity NPC25539
0.5077 Remote Similarity NPC217804
0.5076 Remote Similarity NPC230611
0.5038 Remote Similarity NPC476227
0.5036 Remote Similarity NPC489834

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471053 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data